4.5 Article

Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress

期刊

DIGESTIVE AND LIVER DISEASE
卷 45, 期 12, 页码 1011-1016

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.dld.2013.06.001

关键词

Human colonic muscle cells; Lipopolysaccharide; Lipopolysaccharide-induced motility impairment; Oxidative stress

向作者/读者索取更多资源

Background: Impairment of gastrointestinal motility is frequently observed in patients with severe infection. Aim: To assess whether exposure of human colonic mucosa to pathogenic lipopolysaccharide affects smooth muscle contractility. Methods: Human colonic mucosa and submucosa were sealed between two chambers, with the luminal side facing upwards and covered with Krebs solution, with or without lipopolysaccharide from a pathogenic strain of Escherichia coli (0111:B4; 1000 ng/mL), and with the submucosal side facing downwards into Krebs. The solution on the submuco sal side was collected following 30-min muco sal exposure to Krebs without (N-undernatant) or with lipopolysaccharide (lipopolysaccharide undernatant). Undernatants were tested for lipopolysaccharide and hydrogen peroxide levels and for their effects on smooth muscle cells in the presence of catalase, indomethacin or MG132. Results: Smooth muscle cells incubated with N-undernatant had a maximal contraction of 32 + 5% that was reduced by 62.9 + 12% when exposed to lipopolysaccharide undernatant. Inhibition of contraction was reversed by catalase, indomethacin and MG132. Lipopolysaccharide levels were higher in the lipopolysaccharide undernatant (2.7 + 0.7 ng/mL) than in N-undernatant (0.45 + 0.06 ng/mL) as well as hydrogen peroxide levels (133.75 + 15.9 vs 82 + 7.5 nM respectively). Conclusions: Acute exposure of colonic mucosa to pathogenic lipopolysaccharide impairs muscle cell contractility owing to both lipopolysaccharide mucosal translocation and production of free radicals. (C) 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Virology

Assessment of core and support functions of the communicable disease surveillance system in the Kurdistan Region of Iraq

Soran Amin Hamalaw, Ali Hattem Bayati, Muhammed Babakir-Mina, Domenico Benvenuto, Silvia Fabris, Michele Guarino, Marta Giovanetti, Massimo Ciccozzi

Summary: Early detection and prompt response are crucial in preventing and controlling outbreaks. This study evaluates the performance of the Communicable Disease Surveillance System (CDSS) in the Kurdistan region of Iraq, finding deficiencies in surveillance guiding manuals, data analysis, epidemic preparedness, feedback, and standard guidelines. Strengthening the CDSS in this region requires continuous feedback, supervision, well-trained staff, and coordination between researchers and physicians.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Cell Biology

The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period

Francesco Valentini, Giulia Rocchi, Umberto Vespasiani-Gentilucci, Michele Pier Luca Guarino, Annamaria Altomare, Simone Carotti

Summary: Fetal life and the first few months after birth are crucial periods for adaptation to environmental conditions and can have long-term metabolic consequences and impact on gut microbiota composition, thus affecting future health.
Review Microbiology

Gut Microbiota and COVID-19: Potential Implications for Disease Severity

Giulia Rocchi, Marta Giovanetti, Francesca Benedetti, Alessandra Borsetti, Giancarlo Ceccarelli, Davide Zella, Annamaria Altomare, Massimo Ciccozzi, Michele Pier Luca Guarino

Summary: The SARS-CoV-2 pandemic has caused an unprecedented global crisis. The virus primarily infects the lungs by binding to the ACE-2 cell receptor on the surface of alveolar epithelial cells. Interestingly, this receptor is also found in the epithelial cells of the intestinal tract. Recent data suggests that the gut microbiota may play a role in modulating inflammation. Gastrointestinal symptoms, including diarrhea, are often observed in infected individuals, and there is evidence that the virus can spread through fecal-oral transmission.

PATHOGENS (2022)

Article Medicine, General & Internal

Eosinophilic Esophagitis: Cytokines Expression and Fibrotic Markers in Comparison to Celiac Disease

Annamaria Pronio, Francesco Covotta, Lucia Pallotta, Rossella Palma, Danilo Badiali, Maria Carlotta Sacchi, Antonietta Lamazza, Carola Severi

Summary: The study aims to compare collagen deposition and cytokine expression involved in the fibrogenic response in patients with eosinophilic esophagitis (EoE) and celiac disease. The results show that the inflammatory pathway in EoE is different from celiac disease, and fibrosis mainly occurs in the distal esophagus.

DIAGNOSTICS (2022)

Review Nutrition & Dietetics

The Role of Dietary Fibers in the Management of IBD Symptoms

Claudia Di Rosa, Annamaria Altomare, Elena Imperia, Chiara Spiezia, Yeganeh Manon Khazrai, Michele Pier Luca Guarino

Summary: Inflammatory bowel diseases, including Chron's disease and ulcerative colitis, are chronic immune-mediated diseases of the intestinal tract. Dietary therapy has been shown to be crucial in managing symptoms and pathology of IBD, although there is currently no specific therapeutic diet. Further research is needed to determine the appropriate amount and type of fiber intake for IBD patients.

NUTRIENTS (2022)

Article Gastroenterology & Hepatology

Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients

Alessandra Lo Presti, Federica Del Chierico, Annamaria Altomare, Francesca Zorzi, Giovanni Monteleone, Lorenza Putignani, Silvia Angeletti, Michele Cicala, Michele Pier Luca Guarino, Massimo Ciccozzi

Summary: This study investigated the phylogenetic dynamics of P. copri in patients with IBS, IBD, and healthy volunteers. Results showed longer genetic distances between IBD and healthy volunteers, as well as between IBD and IBS, indicating higher genetic variability in P. copri sequences within IBD. Different strains of P. copri were found in IBS patients, and a correlation between isolates and disease grading was observed. Understanding the phylogenetic characteristics of P. copri is important for better understanding the interactions between microbiota and the pathophysiology of IBD and IBS.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2023)

Article Medicine, General & Internal

Serotonin and Melatonin in Human Lower Gastrointestinal Tract

Rosa Vaccaro, Arianna Casini, Carola Severi, Antonietta Lamazza, Annamaria Pronio, Rossella Palma

Summary: This study examined biopsy samples of normal gastrointestinal mucosa and ulcerative colitis (UC) patients, and found a decrease in the concentration of 5-HT+ cells in UC patients and an increase in the expression of melatonin-secreting cells in severe cases of the disease.

DIAGNOSTICS (2023)

Article Nutrition & Dietetics

Early impairment of food intake in patients newly diagnosed with cancer

Alessio Molfino, Sara Emerenziani, Giuseppe Tonini, Daniele Santini, Antonietta Gigante, Michele Pier Luca Guarino, Chiara Nuglio, Giovanni Imbimbo, Annalisa La Cesa, Michele Cicala, Maurizio Muscaritoli

Summary: This study evaluated the prevalence of anorexia, hypophagia, and cachexia in patients with gastrointestinal or lung cancer at time of diagnosis. The results showed that 68% of patients had cachexia, 57% had anorexia, and 48% had hypophagia. These conditions had negative impacts on patients' nutritional intake, indicating a need for early multimodal strategies to improve food intake.

FRONTIERS IN NUTRITION (2023)

Review Nutrition & Dietetics

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

Claudia Di Rosa, Annamaria Altomare, Vittoria Terrigno, Florencia Carbone, Jan Tack, Michele Cicala, Michele Pier Luca Guarino

Summary: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by abdominal pain and altered bowel habits. The exact cause of IBS is not fully understood, but it is believed to involve a combination of factors such as abnormal gut motility, inflammation, increased intestinal permeability, and sensitivity. Diet and gut microbiota have also been identified as important contributors to IBS. This review examines the effects of dietary components, functional foods, prebiotics, probiotics, and symbiotics on symptoms and gut microbiota in individuals with IBS-C.

NUTRIENTS (2023)

Article Biochemistry & Molecular Biology

Diverticular Disease Worsening Is Associated with Increased Oxidative Stress and Gut Permeability: New Insights by Circulating Biomarkers

Lucia Pallotta, Vittoria Cammisotto, Valentina Castellani, Alessia Gioia, Margherita Spigaroli, Dominga Carlomagno, Simona Bartimoccia, Cristina Nocella, Martina Cappelletti, Stefano Pontone, Roberto Carnevale, Francesco Violi, Rosa Vona, Carla Giordano, Pasquale Pignatelli, Carola Severi

Summary: This study assessed the pathogenesis and potential therapeutic targets of diverticular disease (DD) using circulating biomarkers. It was found that DD patients had decreased antioxidant capacity and increased levels of sNox2-dp, H2O2, and isoprostanes, along with increased TNF-a levels and markers of gut permeability and LPS translocation. These markers were correlated with the severity of DD, suggesting that circulating biomarkers could be used as tools for monitoring disease progression and testing new therapeutic strategies.

ANTIOXIDANTS (2023)

Meeting Abstract Gastroenterology & Hepatology

ROLE OF DIETARY HABITS ON SYMPTOM CONTROL AND GUT MICROBIOTA COMPOSITION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C)

A. Altomare, C. Di Rosa, L. Putignani, S. Emerenziani, S. Fabris, M. Ristori, S. Crucilla, C. Calo, R. Nicolo, M. Ciccozzi, M. Cicala, M. P. L. Guarino

DIGESTIVE AND LIVER DISEASE (2022)

Meeting Abstract Gastroenterology & Hepatology

REDUCED ADHERENCE TO MEDITERRANEAN DIET AND INTESTINAL MICROBIOTA COMPOSITION IN INFLAMMATORY BOWEL DISEASE PATIENTS

A. Altomare, G. Rocchi, F. Zorzi, F. Del Chierico, A. Lo Presti, S. Emerenziani, C. Nuglio, L. Pica, M. Ciccozzi, L. Putignani, M. Cicala, M. P. L. Guarino

DIGESTIVE AND LIVER DISEASE (2022)

暂无数据